Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure'
...le progress in reducing the number of radon-induced lung cancers in the 20 years since the passing of the Indoor Radon Abatement Act (IRAA).
of Milwaukee was diagnosed with lung cancer in 2003 at age 37. She never smoked and had no family history of lung cancer. Curious as to the cause, her...
Program to Identify Likely Victims of Radon-Related Lung Cancer; Survivors Commit to Risk Reduction Despite Failed Government Policy
...t, on those rare opportunities when apparent victims of radon-induced lung cancer can share their personal experiences, people listen. As soon as Liz hoffmann
told her story on WCCO Television in Minneapolis, over 30,000 viewers called to order a radon test kit from the health department. Soon thereafter, th...
Heavy Traffic Can Be Heartbreaking
...igher for those living 100 meters to 200 meters (328 to 642 feet) away.
compares the damage wrought by traffic fumes to the effects of aging. "Livi...k, lowering cholesterol, increasing physical activity and quitting smoking, hoffmann
Reducing air pollution is a larger challenge.
In big U.S. cit...
David W. Keiser to Retire as President of Alexion
...established in 1992,
bringing to the start-up organization nearly 15 years of international
experience with leading pharmaceutical companies including hoffmann
Roche and G.D. Searle. At Alexion, he played a central role in managing the
Company's manufacturing and regulatory efforts, and then initiated the
MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
...he company and its interim president and chief executive officer,
Howard S. hoffmann
of Nightingale Associates, LLC, announced that Mr.
Hoffmann's service as th...Ivie will also continue to serve as the chief technology officer.
was appointed as MedQuist's interim CEO, and
subsequently President, with a...
Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace
medicine during the Summit are:
-- Personalized Medicine: How Industry and Government Can Make it Happen George Abercrombie - CEO, hoffmann
La-Roche, Inc. -- Keynote Address Tevi D. Troy - Deputy Secretary, HHS -- Paying for Innovation: CMS' Approach to Coverage Steve Phurrough -...
Implications of Statin Therapy in Bladder Cancer Patients
...es due to a perceived significant impact on overall mortality from cardiac disease.
In the January issue of the New England Journal of Medicine, hoffmann
and colleagues reported on a series of patients with bladder cancer who were treated with BCG. Of the 84 patients, 19 were also receiving statin thera...
Hoffmann in Medical Technology
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
...mmission filings, including Part II, Item 1A. "Risk Factors" in the Company's first quarter 2009 10-Q, filed May 1, 2009.
C (2007) The epidemiology of HIV coreceptor tropism. Eur J Med Res (2007) 12: 385-390.
2 Atazanavir sulfate is a Bristol-Myers Squibb Company pre...
Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
...icriviroc, a CCR5 inhibitor, in HIV-1-infected,
treatment-experienced patients: AIDS Clinical Trials Group 5211. J Infect
C (2007) The epidemiology of HIV coreceptor tropism. Eur J
Med Res (2007) 12: 385-390.
(6) Atazanavir sulfate is a Bristol-Myers Squibb Company pres...
Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
...g- Plough's Securities and Exchange
Commission filings, including Part I, Item 1A. "Risk Factors" in
Schering-Plough's 2007 10-K/A.
C (2007) The epidemiology of HIV coreceptor tropism. Eur J Med Res (2007) 12: 385-390. 2 Atazanavir sulfate is a Bristol-Myers Squibb Company pres...
AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
...al to develop orally active
anti-cancer drugs," said Dr. Richard Salvador, President and CEO, and the
former global head of Preclinical Development at hoffmann
La Roche, Inc. He
further stated that, "the work embodied in this patent establishes the
'drugability' of the Id proteins as targets allowing the Comp...
Hoffmann in Medical Products
Hoffmann Classic Sterile Wrist Kit
Description:... The hoffmann
C-Series Colles Wrist Fixator is now available in a convenient, single-use sterile kit with all the necessary instrumentation. The surgical technique ...
Company:DePuy Orthopaedics, Inc.
Hoffmann® II Compact™
Features:...radiolucent carbon fiber provides excellent fracture visualization and compact non-bulky frames
Compatible with the Yellow Monotube Triax, the Mini hoffmann
and the Hoffmann® II External Fixation systems
Variable pin placement options allow unlimited frame configurations with a few simple components...
Hoffmann in Biological News
ETH Zurich-administered fund ends scientific anonymity
...acknowledge authors, who invest time and knowledge in their contributions," hoffmann
says in his article.
Clear authorship attribution in this next generati...shing can therefore be enhanced with the advantages of a reputation system. hoffmann
describes how a self-regulating reputation system can help to settle editin...
New breastfeeding study shows most moms quit early
...reastfeeding happens the least," Forste said. "It's a sad irony both in terms of health needs and the expense these families incur buying formula."
said the research suggests future efforts to increase breastfeeding rates could target specific communities and not just individual mothers.
Refusal of suicide order: Why tumor cells become resistant
...occur, this is often caused by tumor cells 'refusing' to take the order to commit suicide," Thomas Hofmann explains.
To prevent HIPK2 degradation, hoffmann
and his colleagues conducted experiments in which they blocked the Siah-1 enzyme. As a result, HIPK2 was able to accumulate even in cells that were on...
'Brains R Us': Neuroscience and education town hall
Brains R Us a town hall on the science of educating, from synapse to schoolroom, neurons to neighborhoods takes place in the Frederic de hoffmann
Auditorium, at the Salk Institute for Biological Studies. The meeting begins at 8 a.m. and runs through 5 p.m., with lunch included and a reception fo...
Balzan Foundation announces 2007 winners
...Paris, for European literature (1000-1500)
Bruce Beutler (USA) and Jules hoffmann
(France), The Scripps Research Institute, La Jolla, California and Acadmie ...ignment of the Prize for Innate Immunity jointly to Bruce Beutler and Jules hoffmann
as follows: "for their discovery of the genetic mechanisms responsible for ...
American Chemical Society's Weekly PressPac -- Aug. 15, 2007
...l now, said Thomas Hofmann and colleagues.
Everybody thinks that caffeine is the main bitter compound in coffee, but thats definitely not the case, hoffmann
said. Only about 15 percent of javas perceived bitterness is due to caffeine, he added, noting that caffeinated and decaffeinated coffee both have sim...
Fruit flies and global warming -- Some like it hot
...") has been known to have negative effects on Drosophila. But Loeschcke and hoffmann
discovered that it can have advantages too. Flies exposed to heat hardening...res, but the heat hardened flies did poorly on cool days.
Loeschcke and hoffmann
did field releases with colored flies exposed to different heat hardening t...
UW-Madison scientists zero in on drugs' sweet spots
...mer UW-Madison graduate student and post-doctoral fellow and now a chemistry professor at Seattle University; Noel R. Peters, and Professor F. Michael hoffmann
of the UW-Madison Comprehensive Cancer Center's Small Molecule Screening Facility; and Ilia A. Guzei, director of crystallography in the UW-Madison de...
Hoffmann in Biological Technology
Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
...e March 2007 issue of the American Journal of Transplantation.
A second comparative clinical study was the ELITE-Symphony study, supported by hoffmann
La Roche, Inc. This study was a prospective, randomized, open-label, multicenter study in four parallel groups of kidney transplant recipients. The t...
Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
..., please visit
(1) IMS MAT dollar sales ending 12/2008
CellCept(R) is a registered trademark of hoffmann
- La Roche, Inc.
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
... AGX51 without any apparent side effects.
In the corporate area, Dr. Richard Salvador, the former global head of Preclinical Development at hoffmann
La Roche, Inc. became Chairman of the Board of Directors and Dr. Garland, who has led the company's drug discovery and development effort, became the ...
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
... William Garland PhD as Chief Executive Officer. Dr. Garland,
formerly with hoffmann
La Roche, Inc., has directed research and
development programs for a number...rman of the
Board, and the former global head of Preclinical Development at hoffmann
Dr. Garland, who designed and directed the pre-clinical st...
Pharmasset Appoints Herbert J. Conrad as a Director
...d serves on the Medical Advisory Board of Henry Schein. From
1960 to 1993, Mr. Conrad served in a variety of marketing and strategic
planning roles at hoffmann
LaRoche, and he was the President of the Roche
Pharmaceuticals Division and a Member of the Executive Committee and Board
of Directors from 1982 throu...
William Garland Joins AngioGenex's New Board of Directors
Development, who is stepping down as Chairman but will remain on the board.
The incoming Chairman added: "After a very productive career at hoffmann
Roche, Inc., Dr. Garland left to run research and development for a number
of successful smaller companies such as Centaur Pharmaceuticals, Atairgi...
So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
... SVP Global Clinical Development & Medical Affairs Glenn Gormley
- Personalized Medicine: How Industry and Government can Make it Happen -- hoffmann
La-Roche Inc. CEO George Abercrombie
- FDAAA and the New Active Surveillance System: What Does Data Mining Mean for the Pharmaceutical Industry? ...
EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
...alls Chief Executive Officer EpiStem Ltd +44-(0)-161-606-7258
Mike Wort, Anna Dunphy MC Bio-Communications Limited +44-(0)-20-7744-7711
Landsbanki Securities (UK) Limited +44-(0)-20-7426-9000
Protein Depletion for Plasma and Serum Proteomic Analysis
...oforms as screening biomarkers of
ovarian cancer. Proteomics 2005, 5 :4625-4636.
Ahmed N, Barker G, Oliva KT, hoffmann P, Riley C, Reeve S, Smith A, Kemp BE,
Quinn MA, Rice GE: Proteomic-based identification of haptoglobin-1
precursor as a novel circulat...
Together with an inverted microscope, combined with hoffmann modulation
contrast optics or
one inverted microscope, in combination with hoffmann modulation contrast
optics or differential interference cont...